Dr. Rahul Aggarwal, MD
Claim this profileUniversity of California, San Francisco
About Rahul Aggarwal, MD
Education:
- Obtained MD from Northwestern University The Feinberg School of Medicine, Class of 2006.
Experience:
- Completed Residency in Internal Medicine at the University of California, San Francisco (UCSF), 2006-2009.
- Undertook Fellowship in Hematology and Medical Oncology at UCSF, 2010-2013.
- Co-Leader of the GU Medical Oncology program and Medical Oncologist within the Division of Hematology/Oncology at UCSF Health.
- Specializes in genitourinary cancers, with a focus on novel therapies and imaging for advanced solid tumor malignancies.
Area of expertise
Prostate Cancer
Rahul Aggarwal, MD has run 22 trials for Prostate Cancer. Some of their research focus areas include:
Solid Tumors
Rahul Aggarwal, MD has run 8 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
University Of California, San Francisco
UCSF Helen Diller Family Comprehensive Cancer Center
Clinical Trials Rahul Aggarwal, MD is currently running
TAB004 + Toripalimab
for Solid Cancers
The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected advanced solid malignancies, including lymphoma, and to evaluate the recommended Phase 2 dose. The secondary objectives are to: 1) describe the pharmacokinetic (PK) profile of TAB004 monotherapy and in combination with toripalimab and to describe the PK profile of toripalimab when administered with TAB004, 2) evaluate antitumor activity of TAB004 monotherapy and in combination with toripalimab; and 3) determine the immunogenicity of TAB004 monotherapy and in combination with toripalimab and to determine the immunogenicity of toripalimab when administered with TAB004. The exploratory objectives are to: 1) evaluate pharmacodynamic effects of TAB004 on its target receptor BTLA, as well as effects on the immune system; 2) evaluate biomarkers that may correlate with activity of TAB004 as monotherapy and in combination with toripalimab; 3) evaluate the utility of BTLA ligand, herpesvirus-entry mediator (HVEM), and additional exploratory biomarkers that could aid in selection of appropriate subjects for TAB004 monotherapy and in combination with toripalimab.
Recruiting
1 award
Phase 1
10 criteria
64Cu-GRIP B PET Imaging
for Genitourinary Cancer
This trial uses a special imaging technique to help see how well the immune system is fighting advanced GU cancers. It targets patients with specific types of advanced cancers and works by highlighting areas where immune cells are attacking cancer cells. This can help predict how well treatments are working.
Recruiting
1 award
Phase 1 & 2
8 criteria
More about Rahul Aggarwal, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Rahul Aggarwal, MD has experience with
- Pembrolizumab
- Apalutamide
- Enzalutamide
- FOR46
- Stereotactic Body Radiation Therapy
- ATR Kinase Inhibitor AZD6738
Breakdown of trials Rahul Aggarwal, MD has run
Prostate Cancer
Solid Tumors
Pancreatic Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rahul Aggarwal, MD specialize in?
Rahul Aggarwal, MD focuses on Prostate Cancer and Solid Tumors. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are Stage III.
Is Rahul Aggarwal, MD currently recruiting for clinical trials?
Yes, Rahul Aggarwal, MD is currently recruiting for 10 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Rahul Aggarwal, MD has studied deeply?
Yes, Rahul Aggarwal, MD has studied treatments such as Pembrolizumab, Apalutamide, Enzalutamide.
What is the best way to schedule an appointment with Rahul Aggarwal, MD?
Apply for one of the trials that Rahul Aggarwal, MD is conducting.
What is the office address of Rahul Aggarwal, MD?
The office of Rahul Aggarwal, MD is located at: University of California, San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.